kairoby Opportune Labs

MOTS-c

MOTS-c is a short peptide encoded within mitochondrial DNA. Research explores how it communicates metabolic signals between mitochondria and the rest of the cell.

Investigational / researchCell and animal evidence
Kairo editorial · Sources reviewed September 9, 20264 sources
On this page
  1. Overview
  2. What the evidence shows
  3. Safety
  4. Common questions
  5. Questions for your clinician
  6. Sources

This entry or formulation may be investigational and may not correspond to an FDA-approved product; safety and efficacy may not have been established. Kairo lists it for identification and record-keeping only.

Overview

Product & regulatory status

Research peptide; endogenous biology and administered products require separate evidence.

Metabolic signaling

Experiments linked MOTS-c to folate-cycle and purine-metabolism changes with downstream AMPK signaling, a cellular energy-sensing pathway. [1]

What the evidence shows

Metabolic research

The original experimental report found that administered MOTS-c improved insulin-related metabolic measures and limited diet-associated obesity in mice. [1]

A human molecule is not a human trial

Finding a peptide in human biology does not establish the safety or benefit of injecting additional peptide. The intervention findings in the cited paper were preclinical. [1]

What remains unknown

The relationship between naturally occurring MOTS-c levels and the effects of a purchased injectable preparation remains a separate question.

Safety

FDA assessment

FDA reports inadequate human exposure information and potential immune-response or impurity concerns for compounded MOTS-c. [2]

Identity and formulation

The research peptide, naturally expressed peptide, and a marketed vial should not be treated as interchangeable sources of evidence. [1]

Understanding product quality

Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [3]

When to seek urgent help

Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [4]

A starting point for discussion

This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.

Common questions

Does this prove an anti-aging effect?

No. Metabolic findings in mice do not establish longer life or better function in humans.

Questions for your clinician

Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?

Sources

  1. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance2015 · Primary research · PubMed
  2. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksFDA · Compound-specific safety assessment
  3. Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
  4. AnaphylaxisMedlinePlus · recognizing an emergency

Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.